Mont-Saint-Guibert, Belgium - Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to attend the following events in June 2019:


Conference details:

BIO International Convention 
Date: June 3 - 6, 2019
Location: Philadelphia, PA
 
William Blair 39th Annual Growth Stock Conference
Date: Wednesday, June 5, 2019
Presentation time: 8:40 – 9:10 a.m. CDT
Location: Chicago, IL
 
HealthTech Investor Days, France Biotech
Date: June 24 - 25, 2019
Location: Paris, France

Download press release(s)

Press release

95.77 Ko

Communiqué de presse

108.69 Ko

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology As...

Next News

Celyad Presents Clinical Update for CYAD-01 at 24th Congress of the European Hematology As...